ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #9,994Hybrid

Vox Sanguinis

Acronym:vox
•
Abbreviation (ISO):VOX SANG
•
Identifier (ISSN):0042-9007(Print)/1423-0410(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
1.6– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Vox Sanguinis

WoS Q3
12342.1120182.3620192.3520202.142021320222.720231.820241.620251.62026
Annual Impact Factor Metric
Current (2026):1.6
Scopus SJR & RankScopus Q2
0.593
#9,994

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
97

97 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate11.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
133articles/year
40.47% Gold OA•85.22% Original Research

Aims & Scope

Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.

Topics Covered (Recognized by AI)
Medicine97%Biology79.7%Immunology68.7%Genetics58.7%Internal medicine52.4%Chemistry44.7%Biochemistry34.8%Antibody34.7%Antigen24.3%Surgery23.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q3
Rank74/103
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q3
Rank67/103
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.6
Articles / Year223
Total Citations71
2025
IF1.6
Articles / Year214
Total Citations308
2024
IF1.8
Articles / Year209
Total Citations607
2023
IF2.7
Articles / Year197
Total Citations711
2022
IF2.996
Articles / Year175
Total Citations966

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,994Scopus Q2SCImago Profile
Scopus Coverage:1952, 1954, 1956-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.593

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.49

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,082 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations810
3-Year Documents502
Citable Documents439

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate51.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ2
Medicine (miscellaneous)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 11.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
3区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Vox Sanguinis (acronym: vox, abbr: VOX SANG, ISSN: 0042-9007) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in England since 1953. The periodical holds a Journal Impact Factor (JIF) of 1.60, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.593 (Q2), an H-index of 97.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 133 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,082 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
1953
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c3630e3d-2ecc-481f-ae7c-85df96aa2b44
Database Updated: 2026-10-01